Skip to Content

NVR LCL (Afinitor 2.5 mg)

Generic Name: everolimus

Pill with imprint NVR LCL is White, Capsule-shape and has been identified as Afinitor 2.5 mg. It is supplied by Novartis Pharmaceuticals Corporation.

Afinitor is used in the treatment of breast cancer; neuroendocrine carcinoma; pancreatic cancer; renal angiomyolipoma; renal cell carcinoma and belongs to the drug classes mTOR inhibitors, selective immunosuppressants. There is positive evidence of human fetal risk during pregnancy. Afinitor 2.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for NVR LCL

Afinitor 2.5 mg NVR LCL

Afinitor

Generic Name
everolimus
Imprint
NVR LCL
Strength
2.5 mg
Color
White
Size
10.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Mtor inhibitors, Selective immunosuppressants
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Novartis Pharmaceuticals Corporation
National Drug Code (NDC)
00078-0594
Inactive Ingredients
butylated hydroxytoluene, crospovidone, hypromelloses, lactose anhydrous, lactose monohydrate, magnesium stearate

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related Images for "NVR LCL"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.